Journal Mobile Options
Table of Contents
Vol. 17, No. 4, 2004
Issue release date: June 2004
Dement Geriatr Cogn Disord 2004;17:337–341
(DOI:10.1159/000077167)

Characterization of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Lomen-Hoerth C.
University of California, San Francisco, Calif., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Amyotrophic lateral sclerosis (ALS) produces progressive weakness, muscular wasting, and spasticity leading to death from respiratory failure at a median of 3 years after onset. ALS and frontotemporal dementia (FTD) overlap in both familial and sporadic cases of ALS. When both occur in families, the affected members may have only ALS, only FTD, or both. This suggests a relationship in the cause of these disorders. We investigated the frequency of ALS in FTD patients and of FTD in ALS patients and found the overlap to be more common than had previously been reported. We report the features of cognitive impairment and pattern of motor involvement in these ALS-FTD patients, and the degree of overlap in both populations.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Rowland LP, Shneider NA: Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688–1700.
  2. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554.
  3. Raymond: Leçon sur les maladies du système nerveux. Paris, Doin, 1889.
  4. Marie P: Leçon sur les maladies de la moelle. Paris, Masson, 1892.
  5. Neary D, Snowden JS, Mann DMA: Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci 2000;180:15–20.
  6. Kato S, Oda M, Hayashi H, Kawata A, Shimizu T: Participation of the limbic system and its associated areas in the dementia of amyotrophic lateral sclerosis. J Neurol Sci 1994;126:62–69.
  7. Jellinger KA: Pick’s disease with ALS. J Neurol Sci 1997;152:227–228.
  8. Hilton DA, Love S, Ferguson I, Newman P: Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathol 1995;90:101–106.
  9. Machida Y, Tsuchiya K, Anno M, et al: Sporadic ALS with multiple system degeneration: A report of an autopsy case without respirator administration. Acta Neuropathol (Berl) 1999;98:512–515.
  10. Kusaka H, Imai T: Pathology of motor neurons in ALS with dementia. Clin Neuropathol 1993;12:164–168.
  11. Kawashima T, Doh-ura K, Kikuchi H, Iwaki T: Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropthol 2001;102:467–472.
  12. Matsumoto S, Goto S, Kusaka H, et al: Ubiquitin-positive inclusion in anterior horn cells in subgroups of motor neuron diseases: A comparative study of adult-onset amyotrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis, and Werdnig-Hoffmann disease. J Neurol Sci 1993;115:208–213.
  13. Niizato K, Tsuchiya K, Tominaga I, Kata Y, Ikeda K: Pick’s disease with ALS: Report of two autopsy cases and literature review. J Neurol Sci 1997;148:107–112.
  14. Nakano I: Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 2000;20:68–75.
  15. Hudson AJ: Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism, and other neurological disorders: A review. Brain 1981;104:217–247.
  16. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W: ALS and PDC of Guam: Forty-year follow-up. Neurology 2002;58:765–773.
  17. McGeer PL, Schwab C, McGeer EG, Haddock RL, Steele JC: Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Neurology 1997;49:400–409.
  18. Lynch TS, Sano M. Marder KS, Bell KL, et al: Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy-complex. Neurology 1994;44:1878–1884.
  19. Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D’Amato CJ, Gilman S, conference participants: Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 1997;41:706–715.
  20. Clark LN, Poorkaj P, Wszolek Z, et al: Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 1998;95:13103–13107.
  21. Hutton M, Lendon CL, Rizzu P, et al: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–705.
  22. Spillantin MG, Goedert M: Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998;21:428–433.
  23. Poorkaj P, Bird TD, Wijsman E, et al: Tau is a candidate gene for chromosome 17 frontotemporal dementia (published erratum appears in Ann Neurol 1998;44:428). Ann Neurol 1998;43:815–825.
  24. Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C: A prospective study of cognitive impairment in ALS. Neurology 1999;53:1665–1670.
  25. Caselli RJ, Windebank AJ, Petersen RC, et al: Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993;33:200–207.
  26. Cavalleri F, De Renzi E: Amyotrophic lateral sclerosis with dementia. Acta Neurol Scand 1994;89:391–394.
  27. Rakowicz WP, Hodges JR: Dementia and aphasia in motor neuron disease: An under recognized association? J Neurol Neurosurg Psychiatry 1998;65:881–889.
  28. Portet F, Cadihac C, Touchon J, Camu W: Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:23–29.
  29. Olney RK, Lomen-Hoerth C: Motor unit number estimation: How may it contribute to the diagnosis of ALS? Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(suppl 2):S41–S49.
  30. Yuen EC, Olney RK: Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis. Neurology 1997;49:573–578.
  31. Jablecki CK, Berry C, Leach J: Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989;12:833–841.
  32. Lomen-Hoerth C, Olney RK: Are motor and sensory responses and motor unit number estimates inherited traits? Clin Neurophysiol, in press.
  33. Brooks BR, Miller RG, Swash M, Munsat TL, for the World Federation of Neurology Research Group on Motor Neuron Diseases: El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(suppl 2):S293–S298.
  34. Lomen-Hoerth C, Anderson T, Miller B: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077–1079.
  35. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094–1097.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50